Matt Dieter
Senior Director at Eli Lilly and Company
- Role
- Executive Director at Eli Lilly and Company
- Location
- Indianapolis, IN, US
- LinkedIn followers
- 500 followers
About Matt Dieter
DABT-certified nonclinical toxicologist with 15+ years of pharmaceutical industry experience in- Design and execution of nonclinical discovery and development strategies for small molecules, monoclonal antibodies, antibody-drug conjugates, and siRNAs, supporting projects within oncology, immunology, and neurodegeneration portfolios - Authorship of nonclinical toxicology content of regulatory filing documents (IBs, IND/CTAs, Marketing Applications, Briefing Packages) and interfacing with worldwide regulatory agencies- Study design, direction and reporting for internal GLP and non-GLP general and exploratory toxicology studies, as well as monitoring of contracted GLP and non-GLP toxicology studies, in support of discovery- and development-stage programs
Experience
Executive Director
Nov 2025 — Present
Education
University of Cincinnati College of Medicine
PhD, Molecular Toxicology
1995 — 2000
University of Cincinnati
B.S., Biology
1990 — 1995
Skills
- Good Laboratory Practice (Glp)
- Glp
- Drug Development
- Immunology
- Assay Development
- Pharmaceutical Industry
- Regulatory Submissions
- Biologics
- In Vivo
- Oncology
- Due Diligence
- Toxicology
- In Vitro
- Clinical Development
- Drug Discovery
- Pharmacology
- Life Sciences
- Biotechnology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.